PFE Pfizer Environmental, Social & Governance (ESG) Data

Employees

Data from SEC filings

Employee count

CEO pay ratio

CEO Salary

Median Employee Salary

ESG framework mentions

In last year of SEC filings

ESG framework	Mentions in filings
Sustainability Accounting Standards Board (SASB)	DEF 14A Definitive proxy 13 Mar 20
Global Reporting Initiative (GRI)	PX14A6G Letter to shareholders 3 Apr 20 DEF 14A Definitive proxy 13 Mar 20
Task Force on Climate-related Financial Disclosures (TCFD)	DEF 14A Definitive proxy 13 Mar 20
UN Sustainable Development Goals (SDGs)	DEF 14A Definitive proxy 13 Mar 20

ESG term mentions

In last year of SEC filings

Air Circular Clean Climate Climate Change Contaminant Emission Environment Environmental Environmental Protection GHG Green Greenhouse Gas Intensity Life Cycle Lifecycle Materials Mineral Natural Resources Nature Offset Package Packaging Pandemic Petroleum Pollutant Pollution Raw Materials Recycling Renewable Resiliency Soil Spill Toxic Waste Wastewater Water Wetland Wind Access Affordability African American Benefits Black California Consumer Privacy Act Charitable Collective Bargaining Collectively Bargained Community Culture Customer Cyber Cybersecurity D&I Data Privacy Data Security Death Demographics Disability Diversity Diversity and Inclusion Drug Pricing Employee Engagement Ethnic Ethnicity Fair Trade Gender General Data Protection Regulation Health and Safety Health Care Healthcare Hire Hiring Human Capital Human Resources Human Rights Incident Injuries Injury Minority Opioid Overtime Pay Equity Pay Parity Perquisites Philanthropic Philanthropy Privacy Product Quality Product Safety Recall Recruit Recruitment Reimbursement Retention Retirement Safety Satisfaction Skill Skills Social Society Stakeholder Supplier Supply Chain Talent Training Union Volunteer Women Workers Workforce Action Plan Anti-corruption Antitrust Assessment Assurance Attorney General Attorneys General Audit Board Effectiveness Board Evaluation Board Oversight Board Refreshment Bonus Bribery Chronic Class Action Lawsuit Classified Classified Board Clawback Commitment Committee Evaluation Conflict of Interest Controversy Corporate Governance Corporate Purpose Corporate Social Responsibility Corruption Department of Enterprise Risk Management ERM ESG Ethics Executive Compensation Expert Fraud Goals Governance Hedging Incentive Incentivize Independence Independent Independent Chair Independent Lead Director Innovate Innovation Innovative Investigation Lawsuit Lead Independent Director Leadership Litigation Long-term Majority Materiality Mission Oversee Oversight Perquisite Plaintiff Pledging Poison Pill Political Expenditures Political Spending Procurement Proxy Access Proxy Contest Purpose Quality Standard R&D Recoup Reputation Reputational Reputational Risk Research and Development Responsibility Responsible Right to Call a Special Meeting Self-evaluation Shareholder Engagement Shareholder Proposals Special Meeting Strategy Sustainability Sustainable Targets Tax Tenure Term Limit Transparency Transparent Voting Rights

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

PFE Pfizer Inc.

Letter to shareholders

PFE Pfizer Inc.

Letter to shareholders

PFE Pfizer Inc.

Letter to shareholders

PFE Pfizer Inc.

Letter to shareholders

PFE Pfizer Inc.

Letter to shareholders

PFE Pfizer Inc.

Letter to shareholders

Vote support at last AGM

(a) The Pfizer Inc. (the "Company") Annual Meeting of Shareholders was held on April 23, 2020.

(b) Shareholders voted on the matters set forth below. 1. The nominees for election to the Company’s Board of Directors set forth in